ECM Therapeutics, Inc.
PrivateLast Round
VC Round
May 28, 2018
Company Overview
ECM Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Pennsylvania. Its latest recorded funding round was a VC Round in May 2018.
ECM Therapeutics, Inc. is a biotechnology company that develops and manufactures therapeutic products derived from extracellular matrix (ECM) for regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ECM Therapeutics, Inc. Comparables
Compare ECM Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RegenX Science | 83% | |
| XM Therapeutics | 74% | |
| Cook Group Incorporated | 74% |
For institutional investors. Book with your work email.
ECM Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ECM Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pittsburgh Investment Office | VC Round |
| Kineticos Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 39% MoM, reaching 2.4K.
- May 28, 2018
$35.2M round with participation from Kineticos Ventures.
For institutional investors. Book with your work email.
ECM Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ECM Therapeutics, Inc.'s valuation, stock price, and market status.
Is ECM Therapeutics, Inc. a public or private company?
ECM Therapeutics, Inc. is a private company.
What is the current stock price of ECM Therapeutics, Inc.?
ECM Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks ECM Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ECM Therapeutics, Inc. worth (valuation)?
Valuation information for ECM Therapeutics, Inc. is not publicly available.
Can I buy ECM Therapeutics, Inc. stock?
ECM Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ECM Therapeutics, Inc.'s last funding round?
ECM Therapeutics, Inc.'s most recent funding round was VC Round on May 28, 2018.
Who are the main investors in ECM Therapeutics, Inc.?
Key investors in ECM Therapeutics, Inc. include University of Pittsburgh Investment Office, Kineticos Ventures.
Will ECM Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for ECM Therapeutics, Inc..
How can I track ECM Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ECM Therapeutics, Inc.'s shares on secondary markets.